GevRx Nutraceuticals, Inc.
New Form D on file · 2026-09-18 · the record
What the record says
Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $300K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Use of proceeds, as written on the filing
While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers.
Company officers on record
On the filing as: Executive Officer, Director.
James Christopher is named as President, Secretary and Treasurer on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
On the filing as: Executive Officer, Director.
Douglas Spiel, M.D. is named as Chief Executive Officer and Chief Medical Director on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
Mary Esposito is named as Director on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
On the filing as: Executive Officer.
Dylan Spiel is named as Vice President on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
On the filing as: Executive Officer.
Michael Betley, Ph.D. is named as Chief Scientific Officer on the Form D that GevRx Nutraceuticals, Inc. filed with the SEC on 18 September 2026, one of 5 people that filing names.
5 people named on the filing — 4 holding an executive role and 1 as a director only.
Named as of the 2026-09-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 5 people named on the filing — 4 holding an executive role and 1 as a director only.
No investor is drawn from a Form D — the form states how many invested and never who.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on GevRx Nutraceuticals, Inc.
- Source Check — verify James Christopher's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with James Christopher for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist GevRx Nutraceuticals, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind GevRx Nutraceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.